As described in section IV.A.4.e.(2)(a)(ii) of this proposed rule, the Rheumatoid Arthritis episode-based cost measure was developed with extensive engagement from interested parties (that is, clinicians who treat this disease, persons with lived experience with Rheumatoid Arthritis, and the general public) through several mechanisms including a TEP, public comment periods, a clinician expert workgroup, person and family engagement opportunities, and national field testing
For years 2018 through 2027, the payment rates established under this section for each CDLT that is not a new ADLT or new CDLT, may not be reduced by more than the following amounts for * * * * * (7) 20240.0 percent of the payment rate established in 2023
We seek comment on whether clinical standards exist that describe and define the disease state of diabetes that would serve to inform the selection of treatment modalities, including potential referrals to dental professionals with respect to concerns related to oral health
Specifically, beginning with the CY 2024 performance period/2026 MIPS payment year, we are proposing that we may reweight one or more of the quality, improvement activities, and Promoting Interoperability performance categories where we determine, based on documentation submitted to us through a reweighting request on or before November 1st of the year preceding the relevant MIPS payment year, that data for a MIPS eligible clinician are inaccessible or unable to be submitted due to circumstances outside of the control of the clinician because the MIPS eligible clinician delegated submission of their data to a third party intermediary, evidenced by a written agreement between the MIPS eligible clinician and the third party intermediary, and the third party intermediary did not submit the data for the performance category(ies) on behalf of the MIPS eligible clinician in accordance with applicable deadlines
(vi) Inflation-adjusted payment amount as specified in 427.302(g)
Removal of 11 MIPS quality measures: 2 MIPS quality measure are duplicative to a proposed new quality measure
